MAP2K7 and neuroblastoma: This study did not look at different RTKs that may be acting together with NF1 to activate SHP2/RAS/MEK, EGFR, and FGFR1, FGFR2 and ALK have been found to associate with SHP2 pathway activation in NB (Zhang et al., 2017).